How much funding has Amigo AI raised?

Amigo AI has raised $17.3M in total funding, most recently a series a round.

Who are Amigo AI's investors?

Amigo AI's investors include General Catalyst, GSV Ventures, Comma Capital, CohoVC.

Where is Amigo AI headquartered?

Amigo AI is headquartered in New York, United States.

What industry is Amigo AI in?

Amigo AI operates in Healthcare.

Amigo AI

The trusted platform for building, training, and deploying clinical agents.

New York, United States · Founded 2023 · $17.3M raised

Healthcare

Headquarters: New York
Employees: 11–50
Founded: 2023
Business Model: B2B

Total Funding: $17.3M
Last Round: $11.0M Series AMar 2026
Rounds: 2

About

Amigo is the trusted platform for building, training, and deploying clinical AI agents that meet the safety and reliability demands of healthcare. The company runs AI agents through millions of simulated patient scenarios — a process called the Digital Residency — before deployment, enabling healthcare organizations to scale clinical capacity 10x while maintaining HIPAA, SOC 2, and GDPR compliance. Amigo integrates natively with all major EHRs and supports over 100 languages across specialties including primary care, behavioral health, cancer care, and women's health.

Summary

Amigo AI is a Healthcare company based in New York, United States, founded in 2023. It has raised $17.3M in total across 2 rounds, most recently a $11.0M Series A round in Mar 2026. Investors include General Catalyst, GSV Ventures and Comma Capital.